The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance.
about
Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indicationsGenetic, hormonal and metabolic aspects of PCOS: an updateRoles of Oxidative Stress in Polycystic Ovary Syndrome and CancersDisordered follicle developmentObesity-induced infertility and hyperandrogenism are corrected by deletion of the insulin receptor in the ovarian theca cellInsulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.Preliminary data on effects of metformin on PED/PEA-15 cellular levels in obese women with polycystic ovary syndrome.In polycystic ovary syndrome, adrenal steroids are regulated differently in the morning versus in response to nutrient intake.The biology of gonadotroph regulation.Polycystic ovary syndrome in the pediatric populationPolycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinthEffects of Adiponectin Including Reduction of Androstenedione Secretion and Ovarian Oxidative Stress Parameters In Vivo.Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study.Adipokines, insulin-like growth factor binding protein-3 levels, and insulin sensitivity in women with polycystic ovary syndromePhosphorylation of human cytochrome P450c17 by p38α selectively increases 17,20 lyase activity and androgen biosynthesis.Polycystic ovary syndrome, obesity and reproductive implications.Impact of obesity on gynecology.An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome.Polycystic ovary syndrome, adipose tissue and metabolic syndrome.Polycystic ovary syndrome throughout a woman's life.CXC Ligand 5 cytokine serum level in women with polycystic ovary syndrome and normal body mass index: A case-control study.Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients.No association between CYP17 -34T/C polymorphism and insulin resistance in Thai polycystic ovary syndrome.Polycystic Ovary Syndrome and Periodontal disease: Underlying Links- A Review.A novel and compact review on the role of oxidative stress in female reproductionGenetic Markers of Polycystic Ovary Syndrome: Emphasis on Insulin Resistance
P2860
Q22242884-86D800A6-C8CF-4133-B875-C2ECAEC97A0BQ26740034-ADF2A264-AB29-44C7-8618-31C667F0DA74Q26771828-9A0CF30A-9180-420E-876B-A9B311BE7336Q26851230-2C6F386D-635E-4F7D-9AEA-4DC8FC31E2CBQ30406039-3AA47F6E-60A1-40FE-A3C2-8E5A7B3E58D7Q33569169-D2500272-B7DD-4AE6-8129-541F9F67B14CQ33645326-6AEC45E9-8B31-4FA2-8C12-F10D8162F01DQ33797004-80A3C6AC-7C28-4410-A9C5-3D2ADCAEC3C9Q33821250-88EFA141-59DD-4E5D-A63D-B209D8CB1104Q35075035-D28F2F9F-B4D1-4A64-8F67-756A66362111Q35100161-B723DD22-B17B-4A26-88F0-04DE0A55E425Q36012055-B09DE682-DE7C-43DF-862C-FA0587A5BE55Q36182504-12FAF12F-0B26-48E8-AC3B-32AD196AD53DQ37015303-B60B0F71-8271-4835-8E2D-EA97BDFC963FQ37099736-377E9B5F-3EE2-44BF-BEEF-72AD4F4ECA0BQ37585306-E1C36DB8-E905-4C2A-829B-BE3443EBF079Q37678420-C78F1874-B260-41D9-88AC-669C4969FB82Q37689166-43A380ED-10D8-49CE-ABFC-A38496A75AD9Q39393050-5B63D64B-6F01-4B92-9B03-02C651AF2947Q47915318-E29DF917-CD30-474B-876E-0CA25452FA02Q49492422-FD018262-5160-4614-BD8E-32C7E4891E0EQ50856309-AFB7D88D-158A-494A-B856-965B3902808DQ53836867-951430A4-DBC0-4BEC-ADF1-6F1F88B798FCQ55395471-A5354031-08E5-432C-8A7B-C383CC36072FQ58736572-520AE4D7-0408-46E5-8B36-013D0CBB300BQ59049526-51906D9D-49AD-463A-BE31-ED9C7CF51F43
P2860
The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The serine phosphorylation hyp ...... enemia and insulin resistance.
@en
The serine phosphorylation hyp ...... enemia and insulin resistance.
@nl
type
label
The serine phosphorylation hyp ...... enemia and insulin resistance.
@en
The serine phosphorylation hyp ...... enemia and insulin resistance.
@nl
prefLabel
The serine phosphorylation hyp ...... enemia and insulin resistance.
@en
The serine phosphorylation hyp ...... enemia and insulin resistance.
@nl
P921
P1476
The serine phosphorylation hyp ...... enemia and insulin resistance.
@en
P2093
Andrew A Bremer
Walter L Miller
P304
P356
10.1016/J.FERTNSTERT.2008.02.091
P407
P577
2008-04-23T00:00:00Z